Watch Sicagen India Limited for free: we tell you when fair value or trend changes.

Sicagen India Limited (SICAGEN) fair value: what the stock is really worth

As of Oct 23, 2026: fair value (intrinsic value) of Sicagen India Limited stock ₹32.81, price ₹48.99, upside -33.0%, quality 64 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? No
Good quality? Yes
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials · IN · ISIN INE176J01011

Thin data Oct 25, 2026

Sicagen India Limited

SICAGEN · BSE

Overvalued / MonitorQuality is not strong enough to offset the price risk.

Our calculation puts a fair price 33% below what the stock costs today.

Quality 64/100

Healthy Growth (revenue 5y +12.4 %/yr in INR)

Low debt

Generates free cash flow

2.0% dividend yield · Well covered

Thin margins · 1.9% net margin (TTM)

Fair value ₹32.81 · Overvalued (−33.0%)

Narrow moat 26/100 · thin data

Thin data

⟳ Cyclical⚠ Thinly traded

26 models, one by oneBear ₹22.92 to bull ₹41.02 Growth analysisrevenue history, year by year Quality 64/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Sicagen India Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 25, 2026.

How to read this chart

60‑month range ₹18.30 – ₹109.30 · fair‑value band ₹22.92 – ₹41.02 · the ₹48.99 price screens above the ₹32.81 fair value. Dashed = 300-day average. As of Oct 25, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Sicagen India Limited, together with its subsidiaries, engages in the trade and distribution of building materials in India and internationally. It operates through Trading and Manufacturing segments.

Show moreShow less

The company distributes building materials, such as MS/GI pipes, precision tubes, structural tubes, seamless tubes, ERW tubes, rectangular/square hollow sections, TMT steel bars, steel fittings, PVC pipes, UPVC pipes, roofing sheets, electrical cables, paints and construction chemicals, lighting solutions, electrical accessories, switchgears, etc. for dealers, contractors, builders, and corporate buyers.

It also offers power and control systems that provides services, sales, and upgrades governing systems, as well as makes switchgears and customized solutions in automation and control sectors.

In addition, the company manufactures mild steel drums and barrels that are used for the transport of lubricant oil, hazardous and non-hazardous chemicals, bitumen, and fruit pulp; builds boats, tugs, and barges; and cables for industrial and other critical applications.

Further, it is involved in the provision of water treatment and process improvement solutions for petrochemical, fertilizer, refinery, power, pharmaceutical, agro, and pesticide industries; and precision fabrication of steel, carbon steel, mild steel, and aluminium; as well as property development activities.

The company was incorporated in 2004 and is based in Chennai, India.

Stock analysis

Sicagen India Limited (SICAGEN) currently trades at ₹48.99, while our model-based Fair Value estimate is ₹32.81, 33.0% below the price, so the stock looks overvalued today.

Valuation

Bull case: the DCF Models group reads highest at a median of ₹139.49 per share, and 22 of the 26 models we run sit above the ₹48.99 price.

Bear case: the Dividend Discount group reads lowest at ₹12.49, and 4 of the 26 models stay below the price. Data coverage for this calculation is low.

Scenario range: ₹22.92 (bear) to ₹41.02 (bull), the price of ₹48.99 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 64/100 (solid quality), in the Basic Materials sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Sicagen India Limited reported revenue of ₹9.7B in FY2025 versus ₹8.4B in FY2021, a compound +3.9%/yr. Reported net income was ₹181M in FY2025.

Key figures

Market cap ₹1.9B (≈ $20.4M) Micro · P/E ratio 9.5 · P/S ratio 0.21 · EPS (TTM) ₹5.17 · Dividend yield 2.0% · Net margin 1.9% · Return on equity 3.7% · Return on assets (EBIT) 3.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 35 out of 100 (low confidence).

What moves the price

The share trades about 33% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −33%, SICAGEN screens cheaper than that median.

Fair Value models

Bear ₹22.92 Fair Value ₹32.81 Bull ₹41.02

Price ₹48.99 · Upside -33.0%

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (₹3.40 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Best data coverage

FCF DCF ₹125.64 ₹181.59 ₹257.60 80

Growth DCF ₹126.27 ₹174.56 ₹235.91 79

Owner Earnings ₹56.30 ₹79.74 ₹111.58 77

All 26 models by family

DCF Models

FCF DCF ₹125.64 ₹181.59 ₹257.60 80

Owner Earnings ₹56.30 ₹79.74 ₹111.58 77

5Y Revenue Exit ₹91.07 ₹130.14 ₹178.63 73

5Y EBITDA Exit ₹105.37 ₹157.06 ₹216.50 75

5Y P/E Exit ₹91.99 ₹131.86 ₹173.00 71

10Y Revenue Exit ₹102.18 ₹139.49 ₹187.59 67

10Y EBITDA Exit ₹112.29 ₹156.74 ₹214.34 69

10Y P/E Exit ₹104.42 ₹140.59 ₹183.62 65

Earnings-Based

Graham-Dodd ₹31.05 ₹100.37 ₹133.98 64

Lynch FV ₹22.34 ₹31.92 ₹41.49 61

PEG = 1.0 ₹22.34 ₹31.92 ₹41.49 57

EPV ₹58.38 ₹65.58 ₹71.60 74

Dividend Discount

Gordon GGM ₹7.87 ₹14.30 ₹19.83 68

DDM Multi-Stage ₹7.87 ₹12.49 ₹15.26 67

Multiples

P/E Multiple ₹71.92 ₹95.89 ₹119.87 63

P/S Multiple ₹58.22 ₹77.63 ₹97.04 58

P/B Multiple ₹422.07 ₹562.75 ₹703.44 55

EV/EBIT ₹61.97 ₹92.58 ₹123.19 65

EV/EBITDA ₹66.98 ₹99.25 ₹131.53 66

EV/Revenue ₹35.68 ₹63.77 ₹91.86 52

Asset-Based

NCAV (Graham) ₹47.58 ₹72.08 ₹90.11 54

Growth DCF

Growth DCF ₹126.27 ₹174.56 ₹235.91 79

Rev-Margin DCF ₹91.07 ₹131.47 ₹178.89 73

Economic Profit

Residual Income ₹87.12 ₹83.24 ₹84.06 76

ROIC Compounder ₹58.38 ₹65.58 ₹71.60 72

Growth Earnings

Growth-Adj P/E ₹60.26 ₹86.09 ₹111.91 67

The fair value above starts from this blend and is adjusted for a cyclical peak year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 64/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 40

How much profit the company makes from its sales and capital

Quality Growth 59

Are margins and returns getting better?

Cashflow 60

Do the profits arrive as real cash?

Financial strength 74

Debt, balance sheet and risk of trouble

Investment 84

Does it invest with discipline instead of growing at any price?

Low Volatility 58

How calm the share price moves, does not count

Momentum 31

Price trend of the last 3 to 12 months, does not count

Near the 52-week high 14

Distance to the 52-week high, does not count

New shares 82

Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 82/100

Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Revenue growth 1 year

+9.1%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+2.8%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+12.4%

Start year 2020 (pandemic)

Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+3.5%

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

What shareholders gained per year (last 3 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.

+10.4%

Earnings growth per share plus dividend.

Earnings per share, growth per year+8.4%

Dividend (yield on the price)2.0%

Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.0% → 3%

Growth Forecast

Little optimism in the price

The price assumes less growth than the company has delivered so far.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

−9.2%

The company could shrink this much every year for the next five years and today's price would still be justified.

What forecasts expect

n/a

No analyst forecast available.

After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about −12.8% a year for the price.

SICAGEN screens overvalued: fair value 33% below the price. Compare with Nucor Corporation →

Compare Sicagen India Limited with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Steel · 401 stocks

Beats the industry median on 8/13 measures

Overall it ranks above its industry peers.

Valuation

Quality Score 64 · Top 25%

Fair Value upside −23.9% · Below median

Profitability

Return on equity (12 months) 3.7% · Below median

Return on assets 2.4% · Above median

Net margin (12 months) 1.9% · Below median

Operating margin (12 months) 2.7% · Below median

Growth and dividend

Revenue growth (quarter YoY) 10.4% · Above median

Dividend yield (12 months) 2.0% · Below median

Valuation Multiplesvs Steel median · lower = cheaper

P/E (12 months) 9.5× · Cheapest 25%

P/B 0.41× · Cheapest 25%

P/S (12 months) 0.21× · Cheapest 25%

Price / free cash flow 5.4× · Cheapest 25%

EV/EBITDA 4.6× · Cheaper than median

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Steel stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value	Compare
Baoshan Iron & Steel Co 600019	¥5.99	¥8.07	+35%	vs SICAGEN
JSW Steel Limited JSWSTEEL	₹1,223	₹1,095	−10%	vs SICAGEN
Tata Steel Limited TATASTEEL	₹172.45	₹148.06	−14%	vs SICAGEN
ArcelorMittal S.A MT	€53.92	€35.54	−34%	vs SICAGEN
Steel Dynamics, Inc STLD	$247.97	$140.62	−43%	vs SICAGEN
POSCO Holdings PKX	$56.22	$29.32	−48%	vs SICAGEN
Reliance, Inc RS	$421.07	$211.54	−50%	vs SICAGEN
Jindal Steel Limited JINDALSTEL	₹1,037	₹516.27	−50%	vs SICAGEN
Nucor Corporation NUE	$264.54	$116.49	−56%	vs SICAGEN
Inner Mongolia Baotou Steel Union Co 600010	¥2.08	¥0.5400	−74%	vs SICAGEN

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator P/E Ratio Calculator PEG Ratio Calculator Graham Number Peter Lynch Formula DDM Calculator Intrinsic Value Intrinsic vs Extrinsic Value P/E Ratio by Sector

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Sicagen India Limited · Fair Value
₹32.81 −33%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/SICAGEN" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Sicagen India Limited · Fair Value</span><br><b style="font-size:20px">₹32.81</b> <span style="color:var(--red);font-weight:700;font-size:14px">−33%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Sicagen India Limited Fair Value". https://www.fairvalue-calculator.com/stock/SICAGEN

Frequently asked questions

Is Sicagen India Limited (SICAGEN) overvalued or undervalued?

As of Oct 25, 2026, our model estimates a fair value of ₹32.81 versus a price of ₹48.99, about −33% upside (overvalued).

What is the fair value of SICAGEN?

Our model-based fair value for Sicagen India Limited is ₹32.81 (as of Oct 25, 2026), built from audited fundamentals. The current price: ₹48.99.

What is the quality score of SICAGEN?

Sicagen India Limited has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Sicagen India Limited (SICAGEN)?

Our model-based price target is the fair value of ₹32.81 (as of Oct 25, 2026) from 26 valuation models. Cautious scenario ₹22.92, optimistic scenario ₹41.02. It is a calculation from audited fundamentals, not an analyst target.

What is the Sicagen India Limited stock forecast for 2026?

Our models put fair value at ₹32.81, about −33% upside versus a price of ₹48.99 (overvalued). Cautious scenario ₹22.92, optimistic scenario ₹41.02. The calculation is refreshed regularly with new filings.

What is the revenue of Sicagen India Limited (SICAGEN)?

Sicagen India Limited reported trailing-twelve-month revenue of about ₹10.5B (latest available figure, as of Oct 25, 2026).

Does Sicagen India Limited pay a dividend?

Sicagen India Limited currently shows a dividend yield of 2.04% relative to its recent price (as of Oct 25, 2026).

What growth is priced into Sicagen India Limited (SICAGEN)?

For today's price to be fair in a discounted-cash-flow model, Sicagen India Limited would have to grow free cash flow by -9.2 % per year for five years (discount rate 10.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +12.4 % per year. As of Oct 25, 2026.

What discount rate (WACC) does the fair value of SICAGEN use?

Our models discount Sicagen India Limited at 10.9 %: a base by market capitalisation (nano), damped by beta 0.25, country premium for India. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Sicagen India Limited that is -9.2 % per year a year over ten years, using the same discount rate (10.9 %) and the same formula as our fair value.

How much growth has Sicagen India Limited (SICAGEN) delivered so far?

Over the past 5 years revenue at Sicagen India Limited grew +12.4 % a year. The price currently implies -9.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Sicagen India Limited (SICAGEN) growing?

The median revenue growth in the sector is +12.5 % a year. That is the yardstick for the growth priced into Sicagen India Limited (-9.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Sicagen India Limited (SICAGEN)?

The free-cash-flow yield on the price is 19.50 %: that much free cash flow Sicagen India Limited produces per unit of market value. When it exceeds the discount rate of our models (10.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Sicagen India Limited (SICAGEN)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sicagen India Limited it is ₹32.81 per share (as of Oct 25, 2026), against a price of ₹48.99. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).

Is Sicagen India Limited stock overvalued or undervalued in 2026?

As of Oct 25, 2026, SICAGEN trades above its calculated fair value: price ₹48.99, fair value ₹32.81, a gap of about −33% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of SICAGEN?

No. The price is what the market pays today (₹48.99); the fair value is what the company's own numbers justify (₹32.81). For Sicagen India Limited the two are ₹16.18 per share apart. That gap is exactly why we show both numbers side by side.

How much is Sicagen India Limited worth?

The market values Sicagen India Limited at about ₹1.9B (market capitalisation, as of Oct 25, 2026). Per share that is ₹48.99; our models calculate a fair value of ₹32.81 per share.

What do the bullish and bearish scenarios say about SICAGEN?

Our models span a range for Sicagen India Limited: cautious scenario ₹22.92, base ₹32.81, optimistic ₹41.02 per share (as of Oct 25, 2026, price ₹48.99). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of SICAGEN?

Sicagen India Limited trades at a price-to-earnings ratio of 9.5 (as of Oct 25, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹32.81 is built from several models across several years. Other multiples: P/B 0.4, P/S 0.2, EV/EBITDA 4.6.

How solid is the balance sheet of Sicagen India Limited (SICAGEN)?

Balance-sheet figures for Sicagen India Limited (as of Oct 25, 2026): return on equity 3.7%. They feed the Quality Score of 64/100, which measures business quality independently of the share price.

How far is SICAGEN from its 52-week high?

Sicagen India Limited trades at ₹48.99, about 33% below its 52-week high of ₹72.82 and 17% above the low of ₹42.02 (as of Oct 23, 2026). Distance from the high says nothing about value: that is what the fair value of ₹32.81 is for.

Which stocks are comparable to Sicagen India Limited?

From the same area (Basic Materials) we also value Nucor Corporation, ArcelorMittal S.A, Steel Dynamics, Inc, JSW Steel Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Sicagen India Limited stock attractive at the current price?

The data as of Oct 25, 2026: price ₹48.99, calculated fair value ₹32.81 (−33%), Quality Score 64/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of SICAGEN calculated?

We run Sicagen India Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹32.81, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 12.3 % above its aggregate fair value. Sicagen India Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Sicagen India Limited (SICAGEN)?

The closing price on Oct 23, 2026 was ₹48.99. Our model-based fair value is ₹32.81, about −33% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Sicagen India Limited right now?

The price sits above even our optimistic bull case (₹41.02). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Sicagen India Limited

How large is the market capitalisation of Sicagen India Limited (SICAGEN)?

The market capitalisation of Sicagen India Limited is ₹1.9B (≈ $20.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Sicagen India Limited (SICAGEN)?

The price-to-sales ratio of Sicagen India Limited is 0.21 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Sicagen India Limited (SICAGEN)?

Earnings per share at Sicagen India Limited are ₹5.17 (price ÷ EPS = P/E 9.5). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Sicagen India Limited (SICAGEN)?

The dividend yield of Sicagen India Limited is 2.0% (payout 19.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Sicagen India Limited (SICAGEN)?

The net margin of Sicagen India Limited is 1.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Sicagen India Limited (SICAGEN)?

The return on equity (ROE) of Sicagen India Limited is 3.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Sicagen India Limited (SICAGEN)?

On an EBIT basis the return on assets of Sicagen India Limited is 3.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Sicagen India Limited (SICAGEN)?

The operating margin of Sicagen India Limited is 3.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Sicagen India Limited (SICAGEN)?

Revenue at Sicagen India Limited is growing +39.8% versus a year earlier (3y avg +2.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Sicagen India Limited (SICAGEN)?

Earnings per share at Sicagen India Limited are growing +52.2% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does Sicagen India Limited (SICAGEN) carry?

The net debt of Sicagen India Limited is ₹1.2B (fiscal year 2025, ≈ 3.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Sicagen India Limited in the live analysis

One click puts Sicagen India Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.